Study of Kidney Function Impairment after Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation. A Single-Center Experience

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 1, 2009, Pages 21-29

  Piñana, Jose Luis ^a   Valcárcel, David ^a   Martino, Rodrigo ^a   Barba, Pere ^a   Moreno, Estela ^a   Sureda, Anna ^a   Vega, Monica ^a   Delgado, Julio ^a   Briones, Javier ^a   Brunet, Salut ^a   Sierra, Jorge ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Acute renal failure; HSCT; Kidney function; Kidney injury; Reduced intensity conditioning Allo RIC

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE KIDNEY FAILURE; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC MYELOID LEUKEMIA; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EXPOSURE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; NEPHROTOXICITY; OVERALL SURVIVAL; REDUCED INTENSITY CONDITIONING; RISK ASSESSMENT; RISK FACTOR; SOLID TUMOR; TREATMENT RESPONSE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORINE; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; KIDNEY FAILURE, ACUTE; MALE; MELPHALAN; METHOTREXATE; MIDDLE AGED; MYCOPHENOLIC ACID; PREMEDICATION; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE; WHOLE-BODY IRRADIATION; YOUNG ADULT;

EID: 58149181345     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.10.011     Document Type: Article

References (30)

1. Ferry C., and Socié G. Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned?. Exp Hematol 31 (2003) 1182-1186
2. Parikh C.R., McSweeney P., and Schrier R.W. Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant. Kidney Int 67 (2005) 1999-2005
3. Kamil E., Latta H., Johnston W., Feig S., and Bergstein J. Radiation nephritis following bone marrow transplantation. Kidney Int (1978) 14
4. Kersting S., Koomans H.A., Hene R.J., and Verdonck L.F. Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival. Bone Marrow Transplant 39 (2007) 359-365
5. Parikh C.R., McSweeney P.A., Korular D., et al. Renal dysfunction in allogeneic hematopoietic cell transplantation. Kidney Int 62 (2002) 566-573
6. Hingorani S.R., Guthrie K., Batchelder A., et al. Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors. Kidney Int 67 (2005) 272-277
7. Zager R.A., O'Quigley J., Zager B.K., et al. Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis 13 (1989) 210-216
8. Hahn T., Rondeau C., Shaukat A., et al. Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients. Bone Marrow Transplant 32 (2003) 405-410
9. Parikh C.R., Sandmaier B.M., Storb R.F., et al. Acute renal failure after nonmyeloablative hematopoietic cell transplantation. J Am Soc Nephrol 15 (2004) 1868-1876
10. Chirag R.P., Robert W.S., Barry S., et al. Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation [abstract]. Am J Kidney Dis 45 (2005) 502-509
11. Parikh C.R., Yarlagadda S.G., Storer B., Sorror M., Storb R., and Sandmaier B.M. Impact of acute kidney injury on long-term mortality after nonmyeloablative hematopoietic cell transplantation. Biol Blood Marrow Transplant 14 (2008) 309-315
12. Kersting S., Dorp S.V., Theobald M., and Verdonck L.F. Acute renal failure after nonmyeloablative stem cell transplantation in adults. Biol Blood Marrow Transplant 14 (2008) 125-131
13. Martino R., Caballero M.D., Canals C., et al. Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study. Br J Haematol 115 (2001) 653-659
14. Smith H. Comparative physiology of the kidney. In: Smith H. (Ed). The Kidney: Structure and Function in Health and Disease (1951), Oxford University Press, New York 520-574
15. Manjunath G., Guruprasad M.J., and Levey A.S. Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertens 10 (2001) 785-792
16. Merouani A., Shpall E.J., Jones R.B., Archer P.G., and Schrier R.W. Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer. Kidney Int 50 (1996) 1026-1031
17. Kaplan E.L., and Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
18. Klein J.P., Rizzo J.D., Zhang M.J., and Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: regression modeling. Bone Marrow Transplant 28 (2001) 1001-1011
19. Klein J.P., Rizzo J.D., Zhang M.J., and Keiding N. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. Bone Marrow Transplant 28 (2001) 909-915
20. Baron F., Maris M.B., Sandmaier B.M., et al. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J Clin Oncol 23 (2005) 1993-2003
21. Atkinson K., Biggs J.C., Hayes J., et al. Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes. Br J Haematol 54 (1983) 59-67
22. Létourneau I., Dorval M., Bélanger R., Légaré M., Fortier L., and Leblanc M. Acute renal failure in bone marrow transplant patients admitted to the intensive care unit. Nephron J 90 (2002) 408-412
23. Gruss E., Bernis C., Tomas J.F., et al. Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome. Am J Nephrol 15 (2008) 473-479
24. Widemann B.C., and Adamson P.C. Understanding and managing methotrexate nephrotoxicity. Oncologist 11 (2006) 694-703
25. Sullivan K.M., Witherspoon R.P., Storb R., et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood 72 (1988) 555-561
26. Parving H.H., Tarnow L., Nielsen F.S., et al. Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study. Diabetes Care 22 (1999) 478-483
27. Qiu J., Tu Z., Shi Y., et al. Interference of cyclosporine on glucose metabolism: potential role in chronic transplantation kidney fibrosis. Transplant Proc 38 (2006) 2065-2068
28. Potter B.J., Giannetti N., Edwardes M.D., Cecere R., and Cantarovich M. Calcineurin inhibitor substitution with sirolimus vs. reduced-dose calcineurin inhibitor plus sirolimus is associated with improved renal dysfunction in heart transplant patients. Clin Transplant 21 (2007) 305-308
29. Schrier R.W., and Parikh C.R. Comparison of renal injury in myeloablative autologous, myeloablative allogeneic and non-myeloablative allogeneic haematopoietic cell transplantation. Nephrol Dial Transplant 20 (2005) 678-683
30. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest physicians/Society of Critical Care Medicine. Chest 101 (1992) 1644-1655